AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3096364 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 19
Study 3096364 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl and Alfentanil (comparison)
Number of subjects: 19
Study 29742652 — intervention group
Group type: EXPERIMENTAL
Intervention: Honeycomb technique with Cavitron Ultrasonic Surgical Aspirator
Number of subjects: 40
Study 29742652 — intervention group
Group type: COMPARATOR
Intervention: Microdissection technique
Number of subjects: 40
Study 29742652 — intervention group
Group type: EXPERIMENTAL
Intervention: Honeycomb technique
Number of subjects: 40
Study 27212181 — intervention group
Group type: EXPERIMENTAL
Intervention: Boswellia, betaine, myo-inositol, B-group vitamins, N-acetylcysteine
Number of subjects: 64
Study 27212181 — intervention group
Group type: COMPARATOR
Intervention: B-group vitamins, N-acetylcysteine (placebo)
Number of subjects: 64
Study 24845963 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated MELD‐XI scores (≥16.8)
Number of subjects: 0
Study 24845963 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal liver function tests (LFTs)
Number of subjects: 0
Study 24845963 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated total bilirubin
Number of subjects: 0
Study 22748747 — intervention group
Group type: EXPERIMENTAL
Intervention: FOR + TIO (Formoterol 12 μg twice a day + Tiotropium 18 μg once a day)
Number of subjects: 38
Study 22748747 — intervention group
Group type: COMPARATOR
Intervention: FOR + PLA (Formoterol 12 μg twice a day + Placebo)
Number of subjects: 38
Study 20002779 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 mg/day rhGH for 40 weeks
Number of subjects: 46
Study 20002779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 17573509 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training (deliberate practice of ACLS scenarios using a human patient simulator)
Number of subjects: 2
Study 17573509 — intervention group
Group type: COMPARATOR
Intervention: Traditional ACLS education (no simulator training)
Number of subjects: 2
Study 11432696 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 5 mg
Number of subjects: 17
Study 11432696 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 10 mg
Number of subjects: 17
Study 11432696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 11432696 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 10 mg with Cyproheptadine (4 mg)
Number of subjects: 17
Study 9466036 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracaine in glucose 10%
Number of subjects: 42
Study 9466036 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine in NaCl 5%
Number of subjects: 42
Study 9466036 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine in glucose 5%
Number of subjects: 42
Study 9466036 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine in NaCl 2.5%
Number of subjects: 42
Study 7949021 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (BC) treatment
Number of subjects: 37
Study 3282479 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (2 to 10 mg daily for eight weeks)
Number of subjects: 126
Study 3282479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 31032364 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for overall survival (OS)
Number of subjects: 6713
Study 31032364 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for cancer-specific survival (CSS)
Number of subjects: 6713
Study 28084515 — intervention group
Group type: EXPERIMENTAL
Intervention: Forsus fatigue resistant device (FRD) with fixed appliances
Number of subjects: 54
Study 28084515 — intervention group
Group type: EXPERIMENTAL
Intervention: Pendulum appliance combined with Nance and headgear followed by fixed appliances
Number of subjects: 54
Study 28084515 — intervention group
Group type: COMPARATOR
Intervention: Extraction of two maxillary premolars with miniscrew anchorage
Number of subjects: 54
Study 25131305 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric
Number of subjects: 50
Study 24427628 — intervention group
Group type: EXPERIMENTAL
Intervention: Lornoxicam
Number of subjects: 45
Study 24427628 — intervention group
Group type: COMPARATOR
Intervention: Tramadol
Number of subjects: 45
Study 20804871 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol + Calcium
Number of subjects: 706
Study 20804871 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Calcium
Number of subjects: 706
Study 20804871 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 706
Study 18978624 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training (ST), n = 9, 45-80% 1RM, 2-4 sets, 20-6 reps
Number of subjects: 28
Study 18978624 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit Training (CT), n = 10, 45-60% 1RM, 2-3 sets, 20-10 reps
Number of subjects: 28
Study 18978624 — intervention group
Group type: COMPARATOR
Intervention: Control (CON), n = 9, no exercise
Number of subjects: 28
Study 16463409 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic opioid use among subjects with rheumatoid arthritis
Number of subjects: 0
Study 16463409 — intervention group
Group type: COMPARATOR
Intervention: Chronic opioid use among subjects with osteoarthritis, chronic low back pain, or ischemic heart disease
Number of subjects: 0
Study 16463409 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-potency opioids prescribed for chronic users
Number of subjects: 0
Study 16463409 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior use of psychiatric medications
Number of subjects: 0
Study 16463409 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior psychiatric diagnosis
Number of subjects: 0
Study 15189630 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-component model of procedural justice
Number of subjects: 0
Study 15189630 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 11015127 — intervention group
Group type: EXPERIMENTAL
Intervention: Week 1 respiratory system resistance (Rrs) measurement
Number of subjects: 46
Study 11015127 — intervention group
Group type: EXPERIMENTAL
Intervention: Week 1 respiratory system compliance (Crs) measurement
Number of subjects: 46
Study 11015127 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple logistic models including week 1 Rrs
Number of subjects: 46
Study 11015127 — intervention group
Group type: EXPERIMENTAL
Intervention: Throughout the 4-week study period
Number of subjects: 46
Study 11015127 — intervention group
Group type: EXPERIMENTAL
Intervention: Rrs results in prediction models
Number of subjects: 46
Study 9174890 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-thickness skin graft
Number of subjects: 0
Study 9174890 — intervention group
Group type: EXPERIMENTAL
Intervention: Edlan-plasty with implants
Number of subjects: 0
Study 9174890 — intervention group
Group type: EXPERIMENTAL
Intervention: Kazanjian-plasty
Number of subjects: 0
Study 9174890 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibuloplasty with keratinized grafts
Number of subjects: 0
Study 9174890 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-thickness skin graft from palate
Number of subjects: 0
Study 9174890 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft from palate
Number of subjects: 0
Study 1606858 — intervention group
Group type: EXPERIMENTAL
Intervention: Slit-suction drainage
Number of subjects: 80
Study 1606858 — intervention group
Group type: COMPARATOR
Intervention: Redon-suction drainage
Number of subjects: 80
Study 30789079 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment methods including word of mouth, email and website advertisements, printed posters, Facebook ads, and a 1-week newspaper ad campaign.
Number of subjects: 102
Study 30789079 — intervention group
Group type: EXPERIMENTAL
Intervention: Gutbusters program (weight loss intervention).
Number of subjects: 102
Study 29329442 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Radiofrequency (CRF)
Number of subjects: 65
Study 29329442 — intervention group
Group type: COMPARATOR
Intervention: Pulsed Radiofrequency (PRF)
Number of subjects: 65
Study 26428353 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free casein-free (GFCF) diet
Number of subjects: 105
Study 26428353 — intervention group
Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 105
Study 23949160 — intervention group
Group type: EXPERIMENTAL
Intervention: WB‐EMS (n = 38)
Number of subjects: 76
Study 23949160 — intervention group
Group type: COMPARATOR
Intervention: aCG (n = 38)
Number of subjects: 76
Study 23276067 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive, family-oriented interventions
Number of subjects: 0
Study 23276067 — intervention group
Group type: COMPARATOR
Intervention: Wait list controls
Number of subjects: 0
Study 20518950 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumiracoxib 100 mg once daily
Number of subjects: 787
Study 20518950 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 600 mg three times daily
Number of subjects: 787
Study 18090405 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous treatment with tenofovir/emtricitabine-based ART
Number of subjects: 16
Study 18090405 — intervention group
Group type: COMPARATOR
Intervention: CD4 cell count-guided interruptions of tenofovir/emtricitabine-based ART
Number of subjects: 16
Study 16889757 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (7 days)
Number of subjects: 221
Study 16889757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study 12663301 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg Ca/d as carbonate)
Number of subjects: 144
Study 12663301 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance at > 50% of exercise sessions
Number of subjects: 144
Study 15321088 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal plus written consent
Number of subjects: 82
Study 15321088 — intervention group
Group type: COMPARATOR
Intervention: Verbal consent
Number of subjects: 82
Study 8639015 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Model
Number of subjects: 930
Study 8639015 — intervention group
Group type: EXPERIMENTAL
Intervention: Office Assisted Model
Number of subjects: 930
Study 8639015 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Center Model
Number of subjects: 930
Study 1738214 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide enteral formula (PEF)
Number of subjects: 41
Study 1738214 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral formula (SEF)
Number of subjects: 41
Study 6427057 — intervention group
Group type: EXPERIMENTAL
Intervention: D100 (all nonprotein calories as dextrose)
Number of subjects: 20
Study 6427057 — intervention group
Group type: EXPERIMENTAL
Intervention: D25 (nonprotein calories as a combination of dextrose and lipid in a 1:3 ratio)
Number of subjects: 20
Study 6427057 — intervention group
Group type: EXPERIMENTAL
Intervention: D75 (nonprotein calories as a combination of dextrose and lipid in a 3:1 ratio)
Number of subjects: 20
Study 6427057 — intervention group
Group type: COMPARATOR
Intervention: D100
Number of subjects: 20
Study 6427057 — intervention group
Group type: EXPERIMENTAL
Intervention: D25
Number of subjects: 20
Study 6427057 — intervention group
Group type: EXPERIMENTAL
Intervention: D75
Number of subjects: 20
Study 31684015 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat, low-fiber meal
Number of subjects: 10
Study 31684015 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat, high-fiber meal
Number of subjects: 10
Study 31684015 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal with high-fiber cereal
Number of subjects: 10
Study 31684015 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meal
Number of subjects: 10
Study 30541594 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated rule-out protocol using combined prehospital copeptin and in-hospital high sensitive troponin (hs-cTn)
Number of subjects: 4800
Study 30541594 — intervention group
Group type: COMPARATOR
Intervention: Standard rule-out protocol using consecutive troponin measurements
Number of subjects: 4800
Study 27732032 — intervention group
Group type: EXPERIMENTAL
Intervention: Circle (confidence interval) visualization
Number of subjects: 0
Study 27732032 — intervention group
Group type: EXPERIMENTAL
Intervention: Faded glyph (probability density function) visualization
Number of subjects: 0
Study 27732032 — intervention group
Group type: EXPERIMENTAL
Intervention: Combining 2 uncertain estimates of location
Number of subjects: 0
Study 27732032 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualization of uncertainty
Number of subjects: 0
Study 24850754 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin at 500 U/kg per week
Number of subjects: 131
Study 24850754 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control arm)
Number of subjects: 131
Study 22133305 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cannabis (THC)
Number of subjects: 0
Study 22133305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20636471 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity human simulation
Number of subjects: 36
Study 20636471 — intervention group
Group type: COMPARATOR
Intervention: Videotaped vignettes
Number of subjects: 36
Study 17496463 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg once daily
Number of subjects: 1279
Study 17496463 — intervention group
Group type: COMPARATOR
Intervention: Ramipril 10 mg once daily
Number of subjects: 1279
Study 15186302 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 20 mg
Number of subjects: 93
Study 15186302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 11783681 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (ACEi)
Number of subjects: 20000
Study 11783681 — intervention group
Group type: EXPERIMENTAL
Intervention: Opportunistic single dipstick test for protein, confirming 24-h urine test for protein, commencement of ACEi
Number of subjects: 20000
Study 11783681 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEi treatment
Number of subjects: 20000
Study 11783681 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-h urine protein test
Number of subjects: 20000
Study 9660339 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive glass synthetic bone graft particles
Number of subjects: 16
Study 7906329 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfortex DeCube mattress
Number of subjects: 44
Study 7906329 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital mattress
Number of subjects: 44
Study 2562546 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 65
Study 132902 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline hydrochloride
Number of subjects: 100
Study 132902 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin hydrate hydrochloride
Number of subjects: 100
Study 31640504 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 0
Study 31640504 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage estimator
Number of subjects: 0
Study 31640504 — intervention group
Group type: EXPERIMENTAL
Intervention: G-estimator
Number of subjects: 0
Study 31242517 — intervention group
Group type: EXPERIMENTAL
Intervention: PD1 inhibitor pembrolizumab
Number of subjects: 0
Study 31242517 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy (vinflunine, docetaxel, or paclitaxel)
Number of subjects: 0
Study 27464970 — intervention group
Group type: EXPERIMENTAL
Intervention: Cixutumumab (20 mg/kg), Pemetrexed (500 mg/m2), Cisplatin (75 mg/m2)
Number of subjects: 172
Study 27464970 — intervention group
Group type: COMPARATOR
Intervention: Control (Pemetrexed and Cisplatin)
Number of subjects: 172
Study 27464970 — intervention group
Group type: EXPERIMENTAL
Intervention: Cixutumumab (20 mg/kg)
Number of subjects: 172
Study 25645666 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-year-old patient case
Number of subjects: 291
Study 25645666 — intervention group
Group type: COMPARATOR
Intervention: 60-year-old patient case
Number of subjects: 291
Study 25645666 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-year-old patient case (surgeons)
Number of subjects: 291
Study 25645666 — intervention group
Group type: COMPARATOR
Intervention: 90-year-old patient case (other consultants)
Number of subjects: 291
Study 25645666 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-year-old patient case (anaesthetists)
Number of subjects: 291
Study 25645666 — intervention group
Group type: COMPARATOR
Intervention: 60-year-old patient case (other consultants)
Number of subjects: 291
Study 23456778 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg/day)
Number of subjects: 154
Study 23456778 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (gemcitabine‐carboplatin)
Number of subjects: 154
Study 22046851 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer education sessions offered in beauty salons
Number of subjects: 984
Study 22046851 — intervention group
Group type: COMPARATOR
Intervention: Diabetes education program (Control)
Number of subjects: 984
Study 19629314 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing consultation and telephone monitoring every 15 days of educational nature
Number of subjects: 0
Study 19629314 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care and monthly telephone monitoring of administrative and epidemiological nature (Control Group)
Number of subjects: 0
Study 16469989 — intervention group
Group type: EXPERIMENTAL
Intervention: MSS milk (milk enriched with calcium from milk solids and tricalcium phosphate)
Number of subjects: 15
Study 16469989 — intervention group
Group type: EXPERIMENTAL
Intervention: CON milk (milk enriched with calcium from concentrated milk)
Number of subjects: 15
Study 16469989 — intervention group
Group type: EXPERIMENTAL
Intervention: FOS milk (milk with added fructo‐oligosaccharides)
Number of subjects: 15
Study 16469989 — intervention group
Group type: EXPERIMENTAL
Intervention: CPP milk (milk with added caseinophosphopeptides)
Number of subjects: 15
Study 16469989 — intervention group
Group type: COMPARATOR
Intervention: Control milk (standard milk)
Number of subjects: 15
Study 16469989 — intervention group
Group type: EXPERIMENTAL
Intervention: TCP added to MSS milk
Number of subjects: 15
Study 12818982 — intervention group
Group type: EXPERIMENTAL
Intervention: Size 5 ProSeal laryngeal mask airway in men
Number of subjects: 90
Study 12818982 — intervention group
Group type: EXPERIMENTAL
Intervention: Size 5 ProSeal laryngeal mask airway in women
Number of subjects: 90
Study 12818982 — intervention group
Group type: COMPARATOR
Intervention: Size 4 ProSeal laryngeal mask airway in women
Number of subjects: 90
Study 10686210 — intervention group
Group type: EXPERIMENTAL
Intervention: Org 31710 (150 mg, every 28 days)
Number of subjects: 50
Study 10686210 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 9139617 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) apheresis using an extracorporeal adsorption column containing dextran sulfate cellulose beads
Number of subjects: 0
Study 9139617 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) apheresis
Number of subjects: 0
Study 1536625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1536625 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 0
Study 6388305 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice, Spaghetti, Lentil (as part of a conventional mixed meal providing 40% of caloric requirement)
Number of subjects: 0
Study 6388305 — intervention group
Group type: EXPERIMENTAL
Intervention: Potato (as part of a conventional mixed meal providing 40% of caloric requirement)
Number of subjects: 0
Study 6388305 — intervention group
Group type: EXPERIMENTAL
Intervention: All carbohydrate sources tested (Rice, Spaghetti, Lentil, Potato)
Number of subjects: 0
Study 31713710 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin receptor/neprilysin inhibitor (ARNI)
Number of subjects: 0
Study 31713710 — intervention group
Group type: COMPARATOR
Intervention: ACEI/ARB
Number of subjects: 0
Study 30802500 — intervention group
Group type: EXPERIMENTAL
Intervention: Benralizumab
Number of subjects: 3
Study 30802500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 28527546 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective blankets
Number of subjects: 328
Study 25303070 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercise (45 minutes, 3 times per week for 8 weeks)
Number of subjects: 37
Study 25303070 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aquatic exercise, maintained normal treatments)
Number of subjects: 37
Study 24050577 — intervention group
Group type: EXPERIMENTAL
Intervention: S. officinalis leaf extract (500 mg capsule t.i.d. for 3 months)
Number of subjects: 40
Study 24050577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 21483279 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical lumbar traction with 50% of body weight
Number of subjects: 30
Study 21483279 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical lumbar traction with 10% of body weight
Number of subjects: 30
Study 19008268 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous BCG (n=5775)
Number of subjects: 11680
Study 19008268 — intervention group
Group type: COMPARATOR
Intervention: Intradermal BCG (n=5905)
Number of subjects: 11680
Study 19008268 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 11680
Study 16283370 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (INT) - 6-10x2 min at 120-140% LT with 1 min rest, 3 days per week for 5 weeks.
Number of subjects: 16
Study 16283370 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity continuous training (CON) - 80-95% LT, 3 days per week for 5 weeks.
Number of subjects: 16
Study 16283370 — intervention group
Group type: EXPERIMENTAL
Intervention: Both INT and CON groups
Number of subjects: 16
Study 12721238 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise program (3 times per week for 12 weeks)
Number of subjects: 155
Study 11753809 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreoid-Depot 160 mg i.m. injection once a month plus 20 mg tamoxifen daily
Number of subjects: 263